Advertisement
Screener

Insys Therapeutics, Inc. Estimated Litigation Liability, Current

Insys Therapeutics, Inc. Estimated Litigation Liability, Current

Insys Therapeutics, Inc. had Estimated Litigation Liability, Current of $115.27 million as of 2019-03-31, per its 10-Q filed 2019-05-13.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current

us-gaap:LitigationReserveCurrent · last filed 2019-05-13

  • 2019-03-31: Estimated Litigation Liability, Current $115.27M.
  • 2018-12-31: Estimated Litigation Liability, Current $41.40M.
  • 2018-09-30: Estimated Litigation Liability, Current $150.06M.
  • 2018-06-30: Estimated Litigation Liability, Current $150.13M.
Period endEstimated Litigation Liability, Current
2019-03-31$115.27M
10-Q · filed 2019-05-13
2018-12-31$41.40M
10-Q · filed 2019-05-13
2018-09-30$150.06M
10-Q · filed 2018-11-09
2018-06-30$150.13M
10-Q · filed 2018-08-09
2018-03-31$151.52M
10-Q · filed 2018-05-10
2017-12-31$150.53M
10-K · filed 2019-03-13
2017-09-30$150.50M
10-Q · filed 2017-11-03
2017-06-30$14.52M
10-Q · filed 2017-08-07
2017-03-31$10.07M
10-Q · filed 2017-05-09
2016-12-31$13.47M
10-K · filed 2018-03-12
2016-09-30$9.57M
10-Q/A · filed 2017-04-07
2016-06-30$9.57M
10-Q/A · filed 2017-04-07
2016-03-31$9.57M
10-Q/A · filed 2017-04-07
2015-12-31$9.57M
10-Q/A · filed 2017-04-07
2015-09-30$9.57M
10-Q/A · filed 2017-04-07
2015-06-30$10.36M
10-Q/A · filed 2017-04-07
2015-03-31$8.14M
10-Q/A · filed 2017-04-07
2014-12-31$0.00
10-Q · filed 2015-08-06